Diagnósticos da América (DASA3) Q3 2026 earnings summary

Executive summary

• 3Q26 gross revenue was R$2.594bn, up 8% on a comparable-scope basis; EBITDA was R$640m at a 26.6% margin, and net income reached R$173m.

• EBITDA excluding equity-method earnings was R$617m, up 4.7% on current scope; operating cash generation was R$456m and free cash flow was R$369m.

• Adjusted net debt fell R$188m QoQ to R$5.435bn; current-scope leverage was 2.76x. Prior-period comparisons are affected by scope changes and non-recurring items.

Financial highlights

• 3Q26 net operating revenue was R$2.410bn, down 7.6% reported; gross profit was R$769m, down 12.7%, with a 31.9% gross margin.

• 9M26 revenue was R$7.409bn, up 10% on current scope; EBITDA excluding equity-method earnings was R$1.636bn, up 17.3%.

• 9M26 net income was R$148m versus a R$526m current-scope loss in 9M25; lower net financial expenses and improved operating performance supported the change.

• 9M26 operating cash generation was R$824m, up 71%; free cash flow reached R$666m, up 121.8%.

Outlook and guidance

• Growth, productivity, financial discipline, cash generation and ongoing financial transformation remain priorities entering 4Q26.

• Selective investment will prioritize technology, infrastructure modernization, maintenance, efficiency and service quality; project timing will determine investment pace.

• Brasília NTO efficiency benefits are expected to build as volumes grow; its initial capacity is 2.4m tests monthly, expandable to 5m without additional construction.

• Q4 activity was tracking expectations, with year-end vacation seasonality expected to follow its usual pattern; no fixed date was given for completing the turnaround.